Rhodiola Rosea (Golden Root)
An adaptogen traditionally used for mental and physical fatigue — research is promising, but less extensive than for ashwagandha.
Number of studies
2
Safety
Moderate
Time to effects
Some people report a subjective improvement within a few days, but clinical trials assessed the effect mainly after 4 weeks of regular use.
Monthly cost
ok. 30–60 zł/miesiąc
Price in Poland
30–60 zł za 60 kapsułek ekstraktu standaryzowanego (miesiąc stosowania)
Who it's for
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
An adaptogen traditionally used for mental and physical fatigue — research is promising, but less extensive than for ashwagandha.
- →Possible reduction of subjective mental fatigue under chronic stress
- →Preliminary data on supporting exercise capacity and faster recovery
- →Possible support for concentration and cognitive function under conditions of fatigue
| Latin name | Rhodiola rosea (golden root) |
|---|---|
| Group/class | Adaptogen |
| Active compounds | Salidroside, rosavin (standardized to approx. 1% / 3%) |
| Form | Standardized root extract (e.g., SHR-5) |
| Evidence level | Preliminary — promising but few and small clinical trials |
| Interactions | Yes — theoretical risk with antidepressants (SSRIs/MAOIs) |
| Status | Dietary supplement, available without prescription |
Understand
Overview
Rhodiola rosea is a plant that grows in cold mountain and arctic climates — in Siberia, Scandinavia, and the mountains of Central Europe — where it has been used for centuries in folk medicine as a remedy against fatigue and to support resilience to harsh conditions (cold, exertion, stress). In Russian and Scandinavian tradition it was sometimes called the 'golden root' and was reportedly given to soldiers and athletes.
Today it's classified as an adaptogen — a substance thought to increase the body's non-specific resistance to various stressors, both physical and psychological, without the excessive stimulation typical of classic stimulants.
Rhodiola tends to help most with chronic mental fatigue linked to stress — that's the profile of participants in most clinical trials, where 28 days of supplementation showed improvement in stress-related fatigue symptoms. It's worth remembering, though, that the evidence base remains preliminary — available reviews describe the results as promising but methodologically heterogeneous and based on relatively small samples. People expecting a strong, immediate stimulant effect similar to caffeine may be disappointed — rhodiola's effect tends to be mild, and improvement usually appears after several days to a few weeks of regular use, not after a single dose. With such a limited number and size of studies, it's also hard to predict in advance who won't respond — a lack of effect doesn't necessarily mean a dosing error; it may simply reflect individual variability that science has yet to describe well.
Where it's found
Rhodiola rosea grows wild in cold mountain and arctic climates — in Siberia, northern Scandinavia, Iceland, and the higher reaches of Central European mountains (including the Carpathians and Sudetes) — usually on rocky, well-drained ground above the tree line. The rhizome and root of the plant are used in supplements.
History of use
Golden root has been used for centuries in the folk medicine of Siberia and Scandinavia as a remedy against physical and mental fatigue and to support resilience to harsh conditions — cold, physical exertion, and stress. In Russian and Scandinavian tradition it was called the 'golden root,' and historical accounts describe it being given to soldiers and athletes to improve endurance. Scientific interest in the plant as an adaptogen developed mainly in the Soviet Union in the mid-20th century, though most clinical trials in humans available today come from the last two decades and remain limited in number.
Mechanism of action
The active compounds (primarily salidroside and rosavin) are being studied for their effects on neurotransmitters (serotonin, dopamine, noradrenaline) and the hypothalamic-pituitary-adrenal (HPA) axis, which may explain the reported anti-fatigue effect. Rhodiola is also being studied for its effects on heat shock proteins (HSP70) and cellular resistance mechanisms to oxidative stress.
Salidroside is sometimes described as inhibiting monoamine oxidase (MAO) activity — the enzyme that breaks down serotonin, dopamine, and noradrenaline — which could theoretically extend their availability in synapses, though most of this data comes from preclinical research (in vitro and animal studies) rather than human trials. Rosavin, in turn, is being studied for its effect on heat shock proteins (HSP70) and antioxidant enzymes such as superoxide dismutase, tied to the hypothesis of 'adaptogenic' protection of cells against oxidative and thermal stress — though this mechanism remains largely hypothetical and requires confirmation in human clinical trials.
Active compounds
The main studied active compounds are salidroside and rosavin, usually standardized at roughly a 1:3 ratio.
Effect on monoamines
Salidroside is studied for inhibiting the breakdown of serotonin, dopamine, and noradrenaline, mainly in preclinical models.
HPA axis modulation
Rhodiola is studied for its effect on the hypothalamic-pituitary-adrenal axis, linked to the reported anti-fatigue effect.
Cellular protection against stress
Rosavin affects heat shock proteins (HSP70) and antioxidant enzymes — a hypothetical mechanism protecting cells from oxidative stress.
Evidence: early-stage — based on 2 studies in this database.
Benefits
Common myths
MythRhodiola is the same thing as ashwagandha, just under a different name.
FactThey are different plants with different effect profiles — rhodiola tends to be described as mildly stimulating and used during the day, while ashwagandha tends to work more relaxingly and is preferred in the evening.
Forms & variants
Rhodiola Rosea (Golden Root) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
Standardized SHR-5 extract
The extract most commonly used in clinical trials, standardized to 3% rosavin and 1% salidroside (a ratio close to the plant's natural composition).
Best for: The default choice — best documented in research
Extracts with elevated rosavin content
Some commercial products artificially raise the rosavin-to-salidroside ratio above the natural 3:1 — there's no evidence such a modification improves effectiveness.
Best for: No advantage over the SHR-5 standard — worth checking the ratio on the label
Raw root powder
A non-standardized traditional form with variable active-compound content between batches.
Best for: Less predictable dosing — a standardized extract is a better choice
Practice
Frequently asked questions
Ashwagandha tends to work more relaxingly and is preferred in the evening, while rhodiola tends to be described as mildly stimulating and used during the day for mental fatigue.
Some herbal medicine traditions recommend cyclical use (e.g., 6–8 weeks with a break) due to the limited number of long-term safety studies — however, there's no hard evidence that such breaks are actually necessary.
The key factor is standardization to 3% rosavin and 1% salidroside — the ratio and concentration used in most clinical trials. Products without a stated standardization are hard to compare in terms of the actual dose of active compounds.
Dosage & timing
Typical dose
200–600 mg of extract standardized to 3% rosavin and 1% salidroside
Form
Standardized root extract
Dosage information is for reference only and reflects the ranges used in the cited studies — it does not replace consultation with a doctor or pharmacist.
Best times to take it
- Morning or before noon — due to its potential stimulating effect
What to combine with
Use caution with
leki przeciwdepresyjne — Medical consultation required when used together
Safety
Side effects & contraindications
Possible side effects
Possible agitation and sleep problems when taken in the evening
Rarely: dry mouth, dizziness
Contraindications
Bipolar disorder — possible risk of triggering a manic episode
Interactions
Antidepressants (SSRIs/MAOIs) — theoretical risk of serotonergic interactions
Is it worth taking?
Who it's for
- People experiencing mental fatigue under chronic stress
- People looking for mild daytime energy support (without stimulation like caffeine)
- Physically active people interested in supporting recovery
Not for
- Bipolar disorder — possible risk of triggering a manic episode
Evidence
Worth knowing
Standardization to 3% rosavin and 1% salidroside is the ratio and concentration used in most clinical trials.
In Russian and Scandinavian tradition, rhodiola was sometimes called the 'golden root.'
The recommended time to take it is morning or before noon, due to its potential stimulating effect.
Studies
In a small randomized placebo-controlled trial (n=60), rhodiola supplementation was associated with improvement in stress-related fatigue symptoms after 28 days of use — a promising result, but one that needs confirmation in larger trials.
Olsson EM, von Schéele B, Panossian AG., Planta Medica, 2009
Rhodiola rosea for physical and mental fatigue: a systematic review
Early-stage evidenceIshaque S, et al. · BMC Complementary and Alternative Medicine · 2012
A systematic review pointing to promising but methodologically heterogeneous evidence for an anti-fatigue effect.
View studyA randomized, double-blind, placebo-controlled study of Rhodiola rosea in stress-related fatigue
Early-stage evidenceOlsson EM, von Schéele B, Panossian AG. · Planta Medica · 2009
An RCT (n=60) showing improvement in stress-related fatigue symptoms after 28 days of supplementation.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
Julia WiśniewskaEditor, Neurohacking & Sleep
Julia writes about nootropics, chronobiology and recovery protocols.
34 publications on this site
Medical review
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.
26 publications on this site
Related entries
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.